Rocket Pharmaceuticals Stops Development of Gene Therapy for Rare Blood Disorder
Rocket Pharmaceuticals has decided to stop developing a gene therapy treatment for a rare blood disorder called Fanconi anaemia. This […]
Rocket Pharmaceuticals has decided to stop developing a gene therapy treatment for a rare blood disorder called Fanconi anaemia. This […]
Creating new medicines is a costly and uncertain process. Startup biotechnology companies often take many years before they can make
In this update, we cover news about making sterile drugs, producing biological treatments, developing cell lines, and creating radiopharmaceuticals. Symbiosis,
A new way to treat a type of cancer has been approved in the United States. The US Food and
A biotech company from the San Francisco Bay Area, Cartography Biosciences, has announced that it has raised $67 million to
The first half of 2025 was a tough time for the Food and Drug Administration (FDA). There were many changes
Japanese drug company Takeda has decided to stop working on cell therapy, a type of treatment that uses patients’ own
AstraZeneca, a major pharmaceutical company, has started an online service in the US where customers can buy medicines directly from
Starting in October 2025, patients in the U.S. without insurance will be able to buy certain AstraZeneca drugs directly from
Lithuania, a country known for its love of basketball, is now making a name for itself in the life sciences